+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

From
Dystrophic Epidermolysis Bullosa - Epidemiology Forecast - 2032 - Product Thumbnail Image

Dystrophic Epidermolysis Bullosa - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 100 Pages
  • Global
From
From
From
Cellulitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cellulitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Actinic Keratosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Actinic Keratosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Neurodermatitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Neurodermatitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Radiodermatitis- Epidemiology Forecast to 2032 - Product Thumbnail Image

Radiodermatitis- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Dyschromia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Dyschromia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Ichthyosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Ichthyosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Vitiligo - Pipeline Insight, 2025 - Product Thumbnail Image

Vitiligo - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Acne Vulgaris- Pipeline Insight, 2025 - Product Thumbnail Image

Acne Vulgaris- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Glabellar Lines - Pipeline Insight, 2025 - Product Thumbnail Image

Glabellar Lines - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Severe Acne Vulgaris - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Acne Vulgaris - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Acne - Pipeline Insight, 2025 - Product Thumbnail Image

Acne - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Bunion - Pipeline Insight, 2025 - Product Thumbnail Image

Bunion - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hidradenitis - Pipeline Insight, 2025 - Product Thumbnail Image

Hidradenitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Moderate To Severe Acne - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Acne - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Neuropathic Pruritus & Postburn Itch - Pipeline Insight, 2025 - Product Thumbnail Image

Neuropathic Pruritus & Postburn Itch - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more